Market Growth and Opportunities - The global military drone market is expected to grow from $16.5 billion in 2022 to $34.3 billion by 2025, with a compound annual growth rate (CAGR) of 27.6%[4] - The company has a significant market opportunity in the anti-drug service market, estimated to reach 3-4 billion yuan annually[16] - The low-altitude economy market in China is expected to exceed RMB 500 billion in 2023, with projections of over RMB 6 trillion by 2035[37] Financial Performance - The company achieved operating revenue of RMB 21,210.34 million in 2023, a decrease of 27.12% compared to the previous year[47] - The net profit attributable to the parent company's shareholders was RMB 2,115.31 million[47] - The basic earnings per share were RMB 0.28, reflecting a decrease of 63.64%[43] - Total revenue for 2023 was approximately $212.1 million, a decrease of 27.12% compared to $291.0 million in 2022[60] - Net profit attributable to shareholders for 2023 was approximately $21.2 million, down 74.31% from $82.3 million in 2022[60] - The net cash flow from operating activities for 2023 was approximately $55.3 million, a decline of 46.82% compared to $104.0 million in 2022[60] - The weighted average return on equity decreased by 5.65 percentage points to 2.92% in 2023 from 8.57% in 2022[60] - The company has experienced a decline in net profit margins, with net profit excluding non-recurring items dropping by 83.07% to approximately $13.3 million in 2023[60] - The total assets increased by 3.77% to approximately $1.07 billion in 2023 from $1.04 billion in 2022[60] Research and Development - The company is actively expanding its research and development capabilities, with multiple laboratories now operational to support new technology development[1] - Research and development investment accounted for 10.71% of operating revenue, an increase of 4.55 percentage points[43] - The company’s R&D process includes demand verification, feasibility studies, and prototype testing, ensuring products meet technical requirements before mass production[19] - The company focuses on data analysis capabilities supported by core interpretation algorithms and a robust database[1] - The company emphasizes the importance of flight verification and has a robust team to support the development and testing of drone technologies[17] Product Development and Services - The company has developed multiple drone models and established high-standard production lines, providing high-quality drone systems and customized product design services[17] - The self-developed T800 multi-scenario intelligent suppression device enhances law enforcement capabilities and fills a gap in domestic stability maintenance applications[17] - The company provides drone flight services and data processing, including drug control, anti-terrorism, resource investigation, and environmental monitoring[48] - The company has established a low-altitude imaging database covering approximately 5 million square kilometers, with an annual increase of no less than 300,000 square kilometers[16] Competitive Landscape - The company is a leading provider of drone anti-drug services in China, leveraging artificial intelligence technology to enhance its competitive advantage in the market[15] - The company has formed deep collaborations with military units in areas such as drone integration and new technology development, enhancing its competitiveness in the military sector[1] - The competitive landscape in the drone industry is intensifying, with production speed, quality consistency, and after-sales service becoming key competitive factors[69] - The industry is characterized by high technical barriers, requiring expertise in multiple disciplines such as aerodynamics and flight mechanics[1] - The company faces significant barriers to entry in the drone industry due to the need for advanced technology and skilled personnel, making it difficult for new entrants to compete[69] Business Model and Operations - The company’s business model includes "make-to-order" production and safety stock, optimizing production efficiency through a combination of in-house and outsourced manufacturing[34] - The company employs a direct sales and distribution model, adapting to government procurement processes and general customer negotiations[34] - The company will continue to monitor key factors affecting its business model and make necessary adjustments[50] - The company has a complete procurement, research and development, production, sales, and service system for its main business[50]

Financial Performance - Operating revenue for the reporting period was CNY 127,997,600.30, a decrease of 17.39% year-on-year[16] - Net profit attributable to shareholders was CNY 31,382,667.38, down 49.42% from the same period last year[16] - The net profit after deducting non-recurring gains and losses was CNY 24,212,078.73, a decline of 59.16% year-on-year[16] - The net cash flow from operating activities was CNY 10,463,999.77, a decrease of 59.07% compared to the previous year[16] - The weighted average return on equity decreased by 3.41 percentage points to 3.09%[16] - Basic and diluted earnings per share were both CNY 0.10, a reduction of 50.00% compared to the previous year[16] Assets and Shareholders - Total assets at the end of the reporting period reached CNY 1,069,294,943.32, an increase of 3.31% compared to the end of the previous year[16] - The company reported a total of 17,593 shareholders at the end of the reporting period[19] R&D Expenditure - R&D expenditure accounted for 14.42% of operating revenue, an increase of 8.52 percentage points year-on-year[16] Report Confirmation - The board of directors confirmed the authenticity, accuracy, and completeness of the semi-annual report[3]

Financial Performance - The company's operating revenue for the current reporting period decreased by 34.02% due to macroeconomic conditions and delays in project acceptance confirmations [5]. - The net profit attributable to shareholders of the listed company decreased by 43.19%, primarily due to the decline in operating revenue and increased R&D and sales expenses for new product market expansion [5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 51.78%, driven by the same factors affecting overall net profit [5]. - The company reported a net profit of RMB 40.25 million for the current period, compared to RMB 77.26 million in the same period last year, reflecting a significant decline [21]. - Basic earnings per share for the current period were RMB 0.02, down from RMB 0.21 in the previous year [21]. - Net profit attributable to shareholders for the first three quarters of 2023 was RMB 40,248,286.54, down 47.9% from the previous year [34]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for the first three quarters of 2023 was RMB 31,724,996.32, a decrease of 57.36% year-on-year [34]. - The company's basic earnings per share for the first three quarters of 2023 were RMB 0.02, a decrease of 48.27% compared to the previous year [34]. - Diluted earnings per share for the current period decreased to -0.42, a decline of 47.90% compared to the previous period [35]. - Net profit attributable to shareholders decreased significantly, leading to a basic earnings per share of -48.27, a drop of 48.27% year-on-year [42]. Revenue and Expenses - Total operating revenue for the first three quarters of 2023 was RMB 169,850,137.27, a decrease of 22.22% compared to RMB 218,385,592.72 in the same period of 2022 [25]. - Operating cash flow for the first three quarters of 2023 showed a net outflow of RMB 489,480.65, a decline of 100.86% compared to the previous year [34]. - Research and development expenses for the first three quarters of 2023 amounted to RMB 18,630,982.46, an increase from RMB 14,064,764.77 in the same period of 2022 [25]. - The company reported a decrease in sales expenses to RMB 5,235,390.58 from RMB 3,914,305.02 in the previous year [25]. - The company’s total operating costs for the first three quarters of 2023 were RMB 121,488,831.92, down from RMB 129,717,143.97 in the same period of 2022 [25]. - Research and development expenses totaled 25,992,442.6 RMB, an increase of 35.22% year-on-year, reflecting the company's commitment to enhancing its product line and expanding into new technology areas [35]. - The proportion of R&D expenses to operating revenue increased by 2.71 percentage points to 18.01% [35]. - The company reported a significant increase in sales expenses due to market expansion efforts [42]. Assets and Liabilities - The total equity attributable to shareholders of the parent company increased to approximately RMB 1,016 million, up from RMB 994 million in the previous period [13]. - The total liabilities and equity amounted to approximately RMB 1,048 million, an increase from RMB 1,035 million in the previous period [13]. - Total assets as of the end of the reporting period were RMB 1,048,272,994.72, compared to RMB 1,035,003,103.19 at the end of the previous year [29]. - Total liabilities decreased to CNY 32,213,805.56 from CNY 40,672,559.95, a reduction of 20.5% [67]. - The total assets as of September 30, 2023, were CNY 1,035,003,103.19, slightly down from CNY 1,035,029,797.54 [74]. - The company’s total equity increased to CNY 683,187,297.63 from CNY 683,241,549.94, a marginal decrease of 0.008% [67]. - The company’s long-term borrowings and bonds payable remained unchanged, indicating stability in financing [67]. - The company maintains a strong capital structure with a significant amount of paid-in capital [75]. - The overall financial position reflects a solid equity base relative to total liabilities [75]. Strategic Focus - The company plans to focus on new product development and market expansion strategies to recover from the current downturn [5]. - The company has identified the need for strategic adjustments in response to the ongoing industry adjustments and macroeconomic challenges [5]. - The company is focusing on the development of new products and technologies in the defense sector, which has led to increased R&D investments [42]. - The company has plans for market expansion and new product development, although specific figures were not disclosed in the report [64].

Financial Performance - The company's operating revenue for Q1 2024 was CNY 47,947,956.58, an increase of 50.8% compared to CNY 31,793,250.98 in Q1 2023[28] - The company reported a comprehensive income total of CNY 5,720,577.47, compared to a loss of CNY 2,284,714.63 in the previous year[24] - The net profit attributable to shareholders for Q1 2024 was CNY 6,197,016.01, showing a significant decrease of 329.18% compared to the same period last year[57] - Net profit for Q1 2024 was ¥6,197,016.01, a turnaround from a net loss of ¥2,703,988.98 in Q1 2023[70] - Basic and diluted earnings per share were CNY 0.08, compared to a loss of CNY 0.01 in the previous period[38] - The weighted average return on equity was 2.92%, an increase of 3.19 percentage points compared to the previous period[80] Cash Flow - The net cash flow from operating activities was CNY 22,971,845.59, up from CNY 16,015,634.86 in the same period last year[12] - The net cash flow from operating activities reached CNY 26,592,198.08, an increase of 67.98% year-on-year[57] - Cash inflow from operating activities totaled CNY 57,154,461.04, an increase from CNY 47,848,908.66 in the same period last year, representing a growth of approximately 19.5%[73] - Cash outflow from operating activities was CNY 30,562,262.96, down from CNY 32,018,719.33, indicating a decrease of about 4.5%[73] - The net increase in cash and cash equivalents was CNY 55,261,406.33, compared to a decrease of CNY 5,048,507.02 in the previous year[81] Assets and Liabilities - The total assets as of March 31, 2024, amounted to CNY 1,071,111,073.18, compared to CNY 1,068,968,929.23 at the end of 2023[29] - The total liabilities as of March 31, 2024, were CNY 63,081,655.27, a decrease from CNY 66,660,088.79 at the end of 2023[29] - The total assets as of the reporting date were ¥1,077,830,320.48, slightly up from ¥1,073,984,222.23 in the previous period[68] - Total liabilities were reported at ¥74,669,257.84, a decrease from ¥77,020,175.60 in the previous period[68] Research and Development - Research and development expenses totaled CNY 13,435,621.07, reflecting the company's commitment to innovation[40] - Research and development expenses in Q1 2024 amounted to ¥14,969,393.47, up from ¥7,137,600.18 in Q1 2023, reflecting an increase of approximately 109.5%[69] - Research and development expenses amounted to CNY 14,969,393.47, representing 31.22% of operating revenue, an increase of 8.77 percentage points year-on-year[80] Market Strategy - The company plans to continue expanding its market presence and investing in new technologies[6] - The company plans to expand its market presence and invest in new technologies to drive future growth[68] Shareholder Information - The total number of common shareholders at the end of the reporting period was 17,378[54] - The largest shareholder, Gao Ming, holds 40.35% of the shares, totaling 149,494,500 shares[54]

证券代码：688287 证券简称：观典防务 公告编号：2024-032 观典防务技术股份有限公司关于上海证券交易所 《2023 年年度报告的信息披露监管问询函》回复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 1、公司近两年存在为客户提供违规担保的情形 公司近两年存在为客户的借款提供违规担保的情形，涉及两家客户分别为蹊 由数据和鹏华科技。蹊由数据、鹏华科技曾作为被担保人，以公司的定期存单作 为质押物进行借款，借款金额分别为 900 万元和 900 万元；同时，蹊由数据和鹏 华科技通过公司的定期保证金质押分别取得 980 万元和 1,800 万元借款资金，上 述借款目前均已结清。近两年，公司对蹊由数据销售额分别为 397.90 万元和 0.00 万元，对鹏华科技的销售额分别为 488.94 万元和 590.27 万元。 2、因收入确认执行政策未有效执行，致使 2023 年年度报告数据与业绩快报 差异较大 2023 年，公司经审计的年度报告营业收入为 21,210.34 万元，业绩快报披露 的营业收入 ...

Financial Performance - The company's operating revenue decreased by 27.12% to CNY 212.10 million compared to the previous year[20] - The company reported a net cash flow from operating activities of CNY 55.30 million, a decline of 46.82% year-on-year[20] - Cash and cash equivalents decreased by 32.52% to CNY 187,579,765.47, accounting for 17.47% of total assets[29] - Accounts receivable increased by 30.02% to CNY 153,578,037.70, representing 14.30% of total assets[29] - Inventory increased by 31.34% to CNY 48,041,268.63, which is 4.47% of total assets[29] - Contract liabilities surged by 2032.01% to CNY 19,208,942.39, making up 1.79% of total assets[29] - Revenue from drone flight services and data processing decreased by 51.55% to CNY 68,547,612.26, with a gross margin of 23.68%[44] - Revenue from unmanned systems and smart defense equipment was CNY 129,094,477.34, with a gross margin of 41.82%[44] - The company reported a total revenue of 162.71 million and a net profit of 25.13 million, reflecting a growth of 19.64% in net profit compared to the previous period[72] Research and Development - Research and development expenses increased by 29.07% to CNY 26.16 million, reflecting the company's commitment to innovation[20] - The number of R&D personnel rose to 41, accounting for 21.47% of the total workforce, slightly down from 21.97%[7] - The company has achieved a total of 320 patent applications, with 266 patents granted cumulatively[2] - The company is focusing on military and police applications in its R&D projects, enhancing its competitive edge in the military sector[13] - The company plans to enhance new product R&D capabilities in smart defense equipment to fill application gaps in stability maintenance and emergency response[38] - The company aims to leverage its advantages in data acquisition and processing to expand into new profit areas such as counter-terrorism patrol and environmental monitoring[39] - The company is focusing on enhancing its drone technology and expanding its product matrix, with an emphasis on intelligent defense equipment and core technologies such as aerodynamic optimization and flight control[59] - The company aims to strengthen its military product strategy by collaborating with universities and improving its mid-to-long-term technology layout, including projects on medium-sized drones and high-speed unmanned aerial vehicles[59] Governance and Management - The company has successfully passed all resolutions in its recent shareholder meetings, indicating strong governance and shareholder support[65] - The company has undergone changes in its board of directors, with new appointments aimed at strengthening governance and oversight[78] - The board of directors held its first meeting on September 6, 2023, to elect the chairman and other key positions[80] - The board of directors approved the third quarter report for 2023 during its second meeting on October 27, 2023[80] - The company has established specialized committees, including an audit committee led by Zhu Bing, a nomination committee led by Diao Weimin, and a strategy committee led by Gao Ming[82] - The board of directors is set to continue its governance and oversight responsibilities, ensuring compliance and strategic alignment[83] - The company is actively involved in the recruitment and appointment of key management personnel to strengthen its leadership team[80] - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 3,606,700[94] - The total remuneration for core technical personnel during the reporting period was CNY 1,844,500[95] - The company has established a comprehensive decision-making and operational system involving the shareholders' meeting, board of directors, and supervisory board[149] Environmental and Social Responsibility - The company has invested CNY 404,300 in environmental protection during the reporting period[150] - The company has established and certified the ISO14001 environmental management system and ISO45001 occupational health and safety management system[154] - The company has implemented strict production management and environmental supervision systems to ensure compliance with national and local standards for emissions[149] - The company has not faced any administrative penalties due to environmental issues during the reporting period[150] - The company actively collaborates with drug control departments using drones and AI technology for precise identification of new drug-related behaviors[157] - The company is committed to deepening environmental awareness and enhancing energy-saving and environmental protection training for employees[143] - The company has maintained stable operation of pollution control equipment, ensuring that emissions meet environmental standards[153] - The company is exploring more environmentally friendly production and operational methods to reduce carbon emissions and optimize resource utilization[149] Shareholder Returns - The company plans to distribute a cash dividend of 0.60 RMB per 10 shares, totaling 22,230,936.00 RMB (including tax) for the fiscal year 2023[133] - The cash dividend represents 105.10% of the net profit attributable to ordinary shareholders, which is 21,153,144.00 RMB[113] - The company is currently in a growth stage and has established a differentiated cash dividend policy based on its development phase and capital expenditure plans[133] - In 2022, the company distributed a cash dividend of 0.60 RMB per 10 shares, with a total cash distribution of 22,230,936.00 RMB (including tax)[133] - The company has not proposed any capital reserve transfer to increase share capital or stock dividends for the 2023 fiscal year[133] - The board of directors will submit the profit distribution proposal to the 2023 annual general meeting for approval[133] Employee Management - The company employed a total of 191 staff members, including 111 production personnel, 41 technical personnel, and 17 sales personnel[106] - The company has established a competitive salary mechanism, including basic salary, position salary, seniority salary, and bonuses[106] - The company has implemented various training programs to enhance employee skills and overall quality[107] - The remuneration for directors and senior management is determined based on their positions, years of service, and performance evaluations[94] - The company has no retired employees requiring financial support, indicating a focus on current workforce management[106] - The independent directors' allowances are set in accordance with general market levels and approved by the shareholders' meeting[94] Product Development - The company has developed the world's first police equipment, the Yellow Hornet T800, which integrates tear gas, restraint, and electric shock functions, enhancing police response capabilities[149] - The company is developing a new non-lethal police equipment with a project budget of RMB 1,900,000, currently in the testing phase[7] - A drone control system project with a budget of RMB 7,300,000 is in the sample trial phase, aimed at enhancing control capabilities in complex electromagnetic environments[8] - The company is working on an upgraded control system for a specific drone model, with a project budget of RMB 4,460,000, currently in the testing phase[9] - A new high-speed, stealth drone platform is under development with a budget of RMB 2,760,000, currently in the sample trial phase[10] - The company is designing a non-gun type tool for multiple scenarios, with a budget of RMB 2,500,000, currently in the design phase[11]

观典防务技术股份有限公司 大信会计师事务所(特殊普通合伙) WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. WUYIGE Certified Public Accoun K 1 1 / Room 2206 22/F,Xueyuan International Tov No.1 Zhichun Road Haidian Dist Belling China, 100083 重大会计差错更正情况审核报告 大信专审字[2024]第 1-00067 号 观典防务技术股份有限公司全体股东: 我们接受委托,审核了贵公司编制的《观典防务技术股份有限公司重大会计差错更正情 况专项说明》（以下简称"重大会计差错更正情况专项说明"）。 一、管理层和治理层的责任 按照企业会计准则及中国证券监督管理委员会《公开发行证券的公司信息披露编报规则 第 19 号 -- 财务信息的更正及相关披露(2020年修订)》、《科创板上市公司自律监管指南 第 3 号 -- 日常信息披露》,真实、准确地编制并披露重大会计差错更正情况专项说明,以 使其不存在虚假记载、误导性陈述或重大遗漏是贵公司管理层的责任。 审核 报 告 ...

证券代码：688287 证券简称：观典防务 公告编号：2024-030 观典防务技术股份有限公司 第四届监事会第四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 观典防务技术股份有限公司（以下简称"公司"）第四届监事会第四次会议于 2024 年 7 月 1 日以现场方式召开，现场会议在公司会议室举行。本次会议的书面通 知于 2024 年 6 月 21 日送达全体监事。会议应出席监事 3 名，实际出席 3 名，会议由 监事会主席王仁发先生主持。会议的召集和召开程序符合有关法律法规、规范性文件 和《公司章程》的规定，会议决议合法、有效。 二、监事会会议审议情况 （一）审议通过《关于前期会计差错更正及追溯调整的议案》 经审议，监事会认为：公司因前期会计差错所进行的财务报表数据追溯调整符合 《企业会计准则第 28 号-会计政策、会计估计变更和差错更正》《公开发行证券的公 司信息披露编报规则第 19 号-财务信息的更正及相关披露》的相关规定，公司对相关 财务报表数据进行的更正及追溯调整，更加客 ...

Financial Performance - Total assets increased by 8.37% to CNY 1,035,003,103.19 in 2022 compared to CNY 955,038,473.23 in 2021[44]. - Operating revenue rose by 26.61% to CNY 291,040,703.73 in 2022 from CNY 229,863,249.05 in 2021[44]. - Net profit attributable to shareholders increased by 13.89% to CNY 82,325,972.02 in 2022 compared to CNY 72,287,866.65 in 2021[44]. - Cash flow from operating activities surged by 86.87% to CNY 103,982,899.75 in 2022 from CNY 55,645,494.75 in 2021[44]. - Basic earnings per share rose by 17.39% to CNY 0.27 in 2022 from CNY 0.23 in 2021[44]. - Research and development expenditure as a percentage of operating revenue decreased by 1.84 percentage points to 8.87% in 2022[44]. - In Q2 2022, operating revenue reached CNY 117,968,833.84, marking a significant contribution to the annual total[45]. - The company’s net profit after deducting non-recurring gains and losses was CNY 78,689,394.46 in 2022, reflecting a 9.14% increase from the previous year[44]. - The net profit attributable to the parent company after deducting non-recurring gains and losses was 78.69 million yuan, with a year-on-year increase of 9.14%[52]. Dividend and Capital Increase - The company plans to distribute a cash dividend of RMB 0.60 per 10 shares, totaling RMB 18,525,780.00, which represents 21.25% of the net profit attributable to shareholders[6]. - The company intends to increase its total share capital from 308,763,000 shares to 370,515,600 shares by issuing 61,752,600 new shares from capital reserves[6]. Research and Development - The company has a strong focus on research and development, continuously innovating and optimizing data processing technologies to enhance its core technical capabilities[12]. - The company focuses on rapid product development based on market demand, with a structured R&D process that includes feasibility studies and prototype testing[25]. - The company is actively involved in the development of smart defense equipment and has established partnerships with various research and testing institutions to enhance its product offerings[19]. - The company is committed to continuous innovation and technology development, with a focus on both short-term and long-term strategic technology advancements[19]. Market Position and Strategy - The company is a leading provider of drone services for drug control, leveraging artificial intelligence technology to create a competitive advantage in the industry[15]. - The company is recognized as a national-level specialized and innovative "little giant" and a high-tech enterprise in the drone industry[12]. - The company aims to capture approximately 25% of the global military drone market by 2024, enhancing its competitive position internationally[42]. - The company has established long-term cooperative relationships with drug control departments since 2010, contributing to training and operational support[15]. Industry Insights - The market size of China's industrial-grade drones grew from 3 billion CNY in 2015 to 27.3 billion CNY in 2020, with a compound annual growth rate (CAGR) of 55.53%[40]. - By 2026, the market size for industrial-grade drones in China is projected to reach approximately 104.1 billion CNY, assuming a growth rate of 25%[41]. - The industrial-grade drone market is increasingly important in applications such as security monitoring, emergency rescue, smart cities, environmental monitoring, aerial surveying, power inspection, and agricultural information[39]. - The drone industry faces high entry barriers, including technological, qualification, production capacity, financial, and manufacturing process barriers[35][36][37]. - The drone industry is characterized by a complex design process that requires expertise in multiple disciplines, including aerodynamics, flight mechanics, and control systems[35]. - The market for industrial-grade drones is expected to continue expanding due to advancements in technology and increasing demand for cost-effective solutions[40]. - The regulatory environment for the drone industry is becoming more favorable, with policies aimed at ensuring safety and promoting healthy development[32]. - The industry is witnessing a shift from military applications to civilian uses, with significant growth in the commercial sector[39]. - The integration of artificial intelligence and data analysis capabilities is crucial for maintaining competitive advantages in the drone industry[35]. Product Development and Innovation - The company has developed multi-scenario intelligent riot control devices, enhancing law enforcement capabilities and filling a gap in the market for stability maintenance and emergency response[18]. - The company has developed innovative non-lethal electric shock weapons, which have been tested and certified by multiple authoritative institutions, showcasing unique structural designs and performance[20]. - The company has accumulated over 30,000 flight hours of practical experience, supporting product improvement and innovation through extensive flight testing[17]. - The company provides comprehensive solutions in various fields, including drug control, counter-terrorism, resource investigation, and environmental monitoring[13]. - The company has established a complete procurement, R&D, production, sales, and service system for its main business, focusing on customized products and maintaining a "sales-driven production + safety stock" procurement model[21]. - The company has achieved full military qualifications and is capable of undertaking military projects, enhancing its competitiveness in the military sector through deep cooperation with military units[19].

证券代码：688287 证券简称：观典防务 公告编号：2024-029 观典防务技术股份有限公司 关于公司股票可能被实施其他风险警示的风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 依据《上海证券交易所科创板股票上市规则》（2024 年 4 月修订）（以 下简称"《上市规则》"）规定，观典防务技术股份有限公司（以下简称"公司"） 股票可能被上海证券交易所实施其他风险警示。请广大投资者注意投资风险。 一、可能被实施其他风险警示的原因 1.实际控制人资金占用情况 公司自查发现截至 2024 年 5 月 29 日，未归还金额共计 15,918.52 万元，构 成实际控制人及其关联方对上市公司的资金占用，占公司最近一期经审计归母净 资产的 15.83%。 2.实际控制人债务偿还承诺 针对实际控制人资金占用事项，公司持续督促实际控制人尽快清偿占用的资 金，公司实际控制人高明先生承诺于 2024 年 10 月 31 日前以现金方式向公司累 计偿还全部占用资金以及按照同期银行贷款基准利率计算的全部资金占用期 ...